Aurora Signorazzi studied Cellular and Molecular Biology at the University of Rome “Tor Vergata”. After an Erasmus internship at the UMCG, she started her PhD in the department of Medical Microbiology, developing cell-based platform technologies to assess vaccine batch-to-batch consistency, specifically regarding Tick-Borne Encephalitis Virus. Her research is part of a European consortium, VAC2VAC, which allows her to work in an international environment, collaborating with other universities and industrial partners. In her spare time she writes as a freelance journalist for DutchReview, an online magazine for expats in the Netherlands.

“Science is a way of thinking much more than it is a body of knowledge” – Carl Sagan

Aurora’s LinkedIn